If you're facing prostate cancer treatment, you might wonder if newer radiation methods can protect your body better. This review looked at proton therapy versus standard photon radiation across different prostate cancer situations.
The review found that proton therapy, especially intensity-modulated proton therapy, reduces the dose to healthy tissue and spares organs better than photon techniques. For early-stage prostate cancer, it shows excellent disease control with low rates of serious side effects. For high-risk patients needing pelvic radiation, studies also show favorable toxicity profiles.
In the postoperative setting, proton therapy offers dosimetric improvements, but its clinical benefits over standard radiation remain less clearly defined. For hypofractionated proton treatment, no significant increases in urinary or bowel toxicity were seen.
The evidence comes from dosimetric studies, prospective work, and registries, so certainty varies. More randomized and cost-effectiveness studies are needed to fully define its role compared to advanced photon techniques.